Featured Research

from universities, journals, and other organizations

Mass screening for prostate cancer in Europe still not recommended

Date:
April 19, 2010
Source:
European Association of Urology
Summary:
The European Association of Urology reiterated that it does not recommend a mass screening policy in Europe for men who are concerned over prostate cancer, a stance which reflects the position it issued last year regarding prostate cancer screening.

The European Association of Urology reiterated that it does not recommend a mass screening policy in Europe for men who are concerned over prostate cancer, a stance which reflects the position it issued last year regarding prostate cancer screening.

Related Articles


"We don't believe that the time has come for mass screening," said EAU Secretary General. Per-Anders Abrahamsson in reply to a query on whether a mass screening policy in Europe would be eventually recommended.

At the media forum held this afternoon which focused on "Prostate cancer screening in Europe- the debate continues" patient organizations, urological professionals and the European Union were represented. Abrahamsson said the EAU reiterates its official position which says that men should be properly informed first by their physician about the pros and cons of screening, such as a PSA test.

Also presenting their views were Prof. Louis Denis, chairperson of patient advocate group Europa Uomo and Alojz Peterle, member of the European Parliament.

"Cancer prevention is one of the key concerns and goals that the European Parliament are working on and we believed that knowledge shared between the medical community, patients and governments is of crucial importance. We need to take action to now," said Peterle.

Denis, on the other hand, focused on strengthening the communication links between patients groups and the medical community as he pointed out that "…education of and proper awareness amongst patients lead to optimum treatment."

The debate on the need for prostate cancer screening came about following the release last year of two major trials, the European Randomised study of Screening for Prostate Cancer (ERSPC) in Europe and the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial in the US.

The ERSPC investigates the value of PSA driven screening in 162,387 men (age 55-70) from eight European countries. Amongst its preliminary conclusions are: men who decide to be PSA-tested have a 31% smaller chance of dying of prostate cancer within nine years and that a larger improvement is expected with longer follow-up.

The ERSPC added that the "possibility of overdiagnosis and overtreatment must be considered" by both the patient and his doctor.

Prof. Freddie Hamdy, moderator of the press forum, underscored that it is important that the media presents an accurate and balanced view to avoid overtreatment in patients whose risks for developing prostate cancer are low.


Story Source:

The above story is based on materials provided by European Association of Urology. Note: Materials may be edited for content and length.


Cite This Page:

European Association of Urology. "Mass screening for prostate cancer in Europe still not recommended." ScienceDaily. ScienceDaily, 19 April 2010. <www.sciencedaily.com/releases/2010/04/100419103005.htm>.
European Association of Urology. (2010, April 19). Mass screening for prostate cancer in Europe still not recommended. ScienceDaily. Retrieved November 27, 2014 from www.sciencedaily.com/releases/2010/04/100419103005.htm
European Association of Urology. "Mass screening for prostate cancer in Europe still not recommended." ScienceDaily. www.sciencedaily.com/releases/2010/04/100419103005.htm (accessed November 27, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Thursday, November 27, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Experimental Ebola Vaccine Shows Promise In Human Trial

Experimental Ebola Vaccine Shows Promise In Human Trial

Newsy (Nov. 27, 2014) — A recent test of a prototype Ebola vaccine generated an immune response to the disease in subjects. Video provided by Newsy
Powered by NewsLook.com
Pet Dogs to Be Used in Anti-Ageing Trial

Pet Dogs to Be Used in Anti-Ageing Trial

Reuters - Innovations Video Online (Nov. 26, 2014) — Researchers in the United States are preparing to discover whether a drug commonly used in human organ transplants can extend the lifespan and health quality of pet dogs. Video provided by Reuters
Powered by NewsLook.com
Today's Prostheses Are More Capable Than Ever

Today's Prostheses Are More Capable Than Ever

Newsy (Nov. 26, 2014) — Advances in prosthetics are making replacement body parts stronger and more lifelike than they’ve ever been. Video provided by Newsy
Powered by NewsLook.com
From Popcorn To Vending Snacks: FDA Ups Calorie Count Rules

From Popcorn To Vending Snacks: FDA Ups Calorie Count Rules

Newsy (Nov. 25, 2014) — The US FDA is announcing new calorie rules on Tuesday that will require everywhere from theaters to vending machines to include calorie counts. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins